Clinical trials
Hospitalization clinical trials
Below are recruiting hospitalization clinical trials, each written for real people, not researchers. We’re tracking 15,631 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07588737Recruiting
AI-Guided Recovery Support After Lung Cancer Surgery
This study uses artificial intelligence and a smartphone app to help monitor your recovery after lung cancer surgery. The goal is to track your symptoms and provide personalized guidance to support your healing and overall well-being.
Guangzhou, GuangdongAges 18–80 - NCT07101588RecruitingPhase 4
Ruxolitinib and decitabine before stem cell transplant for AML
This trial tests whether adding two drugs (ruxolitinib and decitabine) to the standard chemotherapy before a stem cell transplant can help prevent leukemia from coming back. It is for people with acute myeloid leukemia who have a suitable donor and are otherwise healthy enough for transplant.
Beijing, Beijing MunicipalityAges 14–75 - NCT07085182RecruitingPhase 2
Tislelizumab plus radiation for advanced lung cancer
This trial tests combining the immunotherapy drug tislelizumab with radiation therapy for people with advanced non-squamous non-small cell lung cancer that hasn't been treated before. It aims to see if this combination helps control the cancer better than standard treatments.
Zibo, ShandongAges 18–75 - NCT07558083RecruitingPhase 3
Tracking colorectal cancer response using blood tests
This study tests whether a simple blood test can track how well your colorectal cancer is responding to first-line chemotherapy. By monitoring cancer markers in your blood, doctors may be able to detect treatment changes earlier than traditional imaging.
Mechelen, AntwerpenAges 18 years+ - NCT07098351Recruiting
A trial for a new itchy skin medicine for people on peritoneal dialysis
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
Guangzhou, GuangdongAges 18–85 - NCT06152627Recruiting
Voice Therapy for Muscle Tension Dysphonia
This study tests a new way of doing voice therapy for people with muscle tension dysphonia — a condition where the muscles around the voice box are too tight, making it hard to speak clearly. The goal is to see if this structured approach helps improve voice function.
Atlanta, GeorgiaAges 14 years+ - NCT06072989RecruitingPhase 1
B4T2-001 CAR-T infusions for solid tumors without chemo
This trial tests a new kind of cell therapy called CAR-T that targets a protein called BT-001 on solid tumors. It uses repeat infusions and avoids the strong chemotherapy usually given before treatment, which may be easier to tolerate.
Shanghai, China/ShanghaiAges 18–70 - NCT05842109Recruiting
Testing a breath marker to guide care for newborn jaundice
This study looks at a breath-related measurement (from the air you exhale) to help diagnose and guide treatment for jaundice in certain newborns. It may help the care team better decide what care you need after birth, especially when jaundice is related to blood type mismatch.
HangzhouAges Up to 1 week - NCT07549711Enrolling by invitation
Understanding Long Anterior Zonule Eye Condition and Genes
This research study examines a rare eye condition called long anterior zonule (LAZ) that affects the structures supporting the lens. Researchers will compare people with this condition to those without it, and study families where LAZ runs in the family, to understand how genes and physical eye changes relate to this condition.
Fuzhou, FujianAges 18 years+ - NCT07154056Recruiting
Spinal cord stimulation for stubborn nerve pain
This trial tests a new type of spinal cord stimulation for people with long-term nerve pain that hasn't improved with other treatments. The goal is to see if this special stimulation pattern can reduce pain better than standard care.
Poitiers, FranceAges 18–80 - NCT05841771RecruitingPhase 2
Decitabine or azacitidine plus venetoclax after transplant
This trial tests two cancer medicines—decitabine or azacitidine (also called “hypomethylating agents”) plus venetoclax—given after an allogeneic stem cell transplant to help prevent relapse in people with high-risk AML or MDS. If you have measurable remaining leukemia cells after transplant, this study may be especially relevant.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07020572Recruiting
Teen mood support program (iMATTER) in primary care
This study tests a group program to help teenagers with mild to moderate depression symptoms feel better. It takes place in primary care and uses a phone, computer, or tablet for activities.
Philadelphia, PennsylvaniaAges 13–17 - NCT07569068RecruitingPhase 2
Combination Cancer Drugs Before Surgery for Stomach Cancer
This trial tests whether giving immunotherapy and chemotherapy drugs before surgery can help treat stomach cancer that has a specific protein marker (claudin 18.2). The goal is to shrink the tumor and improve outcomes for patients whose cancer can be surgically removed.
Shanghai, Huangpu DistrictAges 18 years+ - NCT07011238Recruiting
Memory B cells and anti-HLA antibodies in kidney transplant patients
This study looks at how memory B cells (a type of immune cell) relate to antibodies against HLA in people waiting for a kidney transplant. It aims to better understand immune responses, which could help improve transplant matching and outcomes.
RouenAges 18 years+ - NCT07416240RecruitingEarly Phase 1
Targeted immune cell therapy for Claudin18.2-positive advanced pancreatic cancer
This early-phase trial is testing a new kind of immune cell therapy—dendritic cells and CAR-T cells—that specifically targets a protein called Claudin18.2 on your cancer cells. It is for people with advanced pancreatic cancer who have already tried standard treatments.
Haikou, HainanAges 18–80 - NCT07593794Recruiting
Quality of Recovery After Heart Surgery Study
This study measures how well patients recover after planned heart surgery by having them answer questions about their physical and emotional wellbeing. The goal is to understand what affects recovery so doctors can better support patients afterward.
KocaeliAges 18 years+ - NCT05052619Recruiting
Check lactate-guided prevention after pancreas surgery
This study looks at whether measuring a blood test called lactate after surgery can help prevent infections inside the belly. You may be eligible if you recently had pancreas surgery and your lactate rises above a certain level within 24 hours.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05837806RecruitingPhase 2
Tislelizumab and disitamab as pre-surgery treatment for HER2 UTUC
This trial tests whether giving tislelizumab plus disitamab vedotin before surgery (neoadjuvant therapy) can improve outcomes for people with HER2-positive, high-risk upper tract urothelial cancer. It also looks at the treatment’s safety and helps doctors learn if certain tumor features predict response.
TianjinAges 18 years+ - NCT07090941Recruiting
Clot removal for severe basilar artery stroke
This trial tests a procedure to remove a blood clot from the main artery at the back of the brain (basilar artery) in people who have a large stroke. The goal is to see if this treatment can improve recovery even when the stroke damage is bigger than usual.
Haikou, HainanAges 18 years+ - NCT05728281Recruiting
See how time after hysterectomy affects sexual function
This study looks at how sexual well-being changes over time after a hysterectomy (removal of the uterus). It may help doctors better understand what to expect and how to support recovery related to sexual function.
AngersAges 18 years+ - NCT06987877Recruiting
Saline flushes to keep kidney tubes working
This study tests if flushing a kidney drainage tube with saline helps prevent blockages. It may help people who have a tube in their kidney and need it for at least 12 weeks.
Boston, MassachusettsAges 18–80 - NCT06387056RecruitingPhase 2
Gene-guided hormone therapy before prostate cancer surgery
This trial tests whether giving a combination of hormone treatments before surgery can improve outcomes for men with prostate cancer that has spread locally or to a few bone spots. It uses genetic testing to match participants with the most effective treatment.
Xiamen, FujianAges 18 years+ - NCT07089862Recruiting
Indobufen vs aspirin for unruptured brain aneurysm treatment
This trial compares two anti-clotting drugs—indobufen and aspirin—to see which works better for people getting a stent or flow diverter for an unruptured brain aneurysm. The goal is to find which drug causes fewer bleeding or clotting problems.
Beijing, Beijing MunicipalityAges 18–75 - NCT07156422Recruiting
Study of sensitive scalp in women without skin disease
This study is for women who have a sensitive scalp — feeling itchy, burning, or uncomfortable — but no scalp disease like psoriasis. Researchers want to understand what causes this sensitivity so they can help people like you.
BrestAges 18 years+
Hear when a new Hospitalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hospitalization?
- Yes. Clin2 currently lists 15,631 recruiting hospitalization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hospitalization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hospitalization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.